Impact of Direct Oral Anticoagulant Off-Label Reduced Dose in Combination With Antiplatelet Agents on Clinical Outcome　― Propensity Score-Matching Analysis From the DIRECT Real-World Non-Valvular Atrial Fibrillation Registry ―

Background: The association between direct oral anticoagulant (DOAC) dose and clinical outcomes when used with antiplatelets still remains to be investigated. Methods and Results: We conducted a prospective registry of non-valvular atrial fibrillation (AF) patients with DOAC: the DIRECT registry (n=...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Tomoaki, Sotomi, Yohei, Hirata, Akio, Sakata, Yasushi, Hirayama, Atsushi, Higuchi, Yoshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925311/
https://www.ncbi.nlm.nih.gov/pubmed/33693243
http://dx.doi.org/10.1253/circrep.CR-20-0026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925311/
https://www.ncbi.nlm.nih.gov/pubmed/33693243
http://dx.doi.org/10.1253/circrep.CR-20-0026

Ejemplares similares